Search

Your search keyword '"Wessels, Lodewyk F. A."' showing total 665 results

Search Constraints

Start Over You searched for: Author "Wessels, Lodewyk F. A." Remove constraint Author: "Wessels, Lodewyk F. A."
665 results on '"Wessels, Lodewyk F. A."'

Search Results

1. Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer: a phase 2 adaptive trial

3. ecpc: An R-package for generic co-data models for high-dimensional prediction

5. Percolate: An Exponential Family JIVE Model to Design DNA-Based Predictors of Drug Response

7. PD-L1 blockade in combination with carboplatin as immune induction in metastatic lobular breast cancer: the GELATO trial

8. Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer

9. Flexible co-data learning for high-dimensional prediction

10. γδ T cells are effectors of immunotherapy in cancers with HLA class I defects

11. Heterofusion: Fusing genomics data of different measurement scales

13. Neoadjuvant Immunotherapy in Locally Advanced Mismatch Repair–Deficient Colon Cancer

15. Truncated FGFR2 is a clinically actionable oncogene in multiple cancers

16. Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancer

17. Generalized simultaneous component analysis of binary and quantitative data

18. Approximating multivariate posterior distribution functions from Monte Carlo samples for sequential Bayesian inference

19. Extensive androgen receptor enhancer heterogeneity in primary prostate cancers underlies transcriptional diversity and metastatic potential

22. DNA damage induces p53-independent apoptosis through ribosome stalling

23. Efficacy of pembrolizumab and biomarker analysis in patients with WGS-based intermediate to high tumor mutational load: results from the Drug Rediscovery Protocol

25. Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trial

27. Publisher Correction: Truncated FGFR2 is a clinically actionable oncogene in multiple cancers

28. DNA damage induces p53-independent apoptosis through ribosome stalling.

30. Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasis

31. Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial

32. A network analysis to identify mediators of germline-driven differences in breast cancer prognosis

35. Comparative oncogenomics identifies combinations of driver genes and drug targets in BRCA1-mutated breast cancer

38. Spatial relationships in the urothelial and head and neck tumor microenvironment predict response to combination immune checkpoint inhibitors

39. Abstract 5786: Spatial relationships in the tumor microenvironment predict response to immune checkpoint inhibitors in urothelial and head and neck cancer

40. Abstract 3488: Truncated FGFR2 - a clinically actionable oncogene in multiple cancers

49. Supplementary Information from Pretreatment microRNA Expression Impacting on Epithelial-to-Mesenchymal Transition Predicts Intrinsic Radiosensitivity in Head and Neck Cancer Cell Lines and Patients

Catalog

Books, media, physical & digital resources